$1.22
-0.02-1.61%
At close: -
$1.10
-0.12-9.84%
After Hours: May 2, 8:00 AM EDT
Comments
Loading...
AN2 Therapeutics Stock Guidance | NASDAQ:ANTX | Benzinga
AN2 Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AN2 Therapeutics Inc (ANTX) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for AN2 Therapeutics (ANTX)?
There have been no specific sales or earnings guidance reported for AN2 Therapeutics in recent months.
Browse guidance and forecast on all stocks.
